Industry Developments

BMI View: We warned throughout 2011 that drug pricing controls were likely to spread within the Gulf Cooperation Council (GCC). The establishment of a joint GCC drug pricing unit vindicates... 2012-01-11

BMI View: Algeria is a high-risk market for multinational drugmakers because of the combination of regional uncertainty and state interference in its business environment. The country's... 2012-01-06

BMI View: The recent increase in immigration to the UAE is good for total market size but increasingly it is becoming divided between indigenous nationals/expatriate professionals and... 2012-01-05

BMI View: It can be difficult to substantially increase healthcare spending overnight without building new social infrastructure and developing better human resources, which is a lengthy... 2012-01-03

BMI View: We are encouraged by the fact that the Tanzanian government has placed a greater emphasis on development expenditure, highlighting healthcare as a key area of investment,... 2011-12-30

BMI View: The commissioning of three anti-larvicide factories in West Africa is good news for the Cuban company building them and the region. While the biolarvicide chemicals had been... 2011-12-28

BMI View: We believe a healthy local pharmaceutical industry is important for both the economic development of African countries and the provision of public healthcare. For too long,... 2011-12-23

BMI View: Tunisia has a small but dynamic pharmaceutical market. It has a significant proportion of pharmaceuticals provided by local drugmakers and wholesale and retail mark-ups are... 2011-12-22

BMI View: We have long been sceptical about the differences between the Iraqi government's healthcare budget and what actually is spent. While previously we attributed this difference... 2011-12-21

BMI View: Locking up doctors and arresting patients suspected of participating in protests will make Bahrain unattractive to local and foreign medical professionals, increase over-the-counter... 2011-12-19